NEKTAR THERAPEUTICS Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nektar Therapeutics quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Nektar Therapeutics Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 193M shares, a 1.03% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 193M +1.97M +1.03% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 192M +2.23M +1.17% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 192M Mar 31, 2024 10-Q 2024-05-10
Q4 2023 191M +2.82M +1.5% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 191M Sep 30, 2023 10-Q 2023-11-08
Q2 2023 190M Jun 30, 2023 10-Q 2023-08-09
Q4 2022 189M +3.09M +1.67% Dec 31, 2022 10-K 2024-03-05
Q4 2021 185M +5.38M +2.99% Dec 31, 2021 10-K 2023-02-28
Q4 2020 180M +3.59M +2.03% Dec 31, 2020 10-K 2022-03-01
Q4 2019 177M +2.98M +1.71% Dec 31, 2019 10-K 2021-02-26
Q4 2018 174M +14M +8.78% Dec 31, 2018 10-K 2020-02-28
Q3 2018 173M +16.1M +10.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 172M +16.6M +10.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 162M +7.65M +4.94% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 160M +6.31M +4.12% Dec 31, 2017 10-K 2019-03-01
Q3 2017 157M +19.2M +13.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 156M +19.3M +14.1% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 155M +18.6M +13.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 153M +17.9M +13.2% Dec 31, 2016 10-K 2018-03-01
Q3 2016 138M +4.58M +3.44% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 137M +4.42M +3.34% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 136M +4.7M +3.58% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 135M +4.07M +3.1% Dec 31, 2015 10-K 2017-03-01
Q3 2015 133M +4.97M +3.88% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 132M +4.9M +3.85% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 131M +4.52M +3.56% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 131M +14.7M +12.6% Dec 31, 2014 10-K 2016-03-01
Q3 2014 128M +12.3M +10.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 127M +11.6M +10% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 127M +11.5M +9.94% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 116M +1.24M +1.07% Dec 31, 2013 10-K 2015-02-26
Q3 2013 116M +917K +0.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 116M +903K +0.79% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 115M +870K +0.76% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 115M +774K +0.68% Dec 31, 2012 10-K 2014-02-27
Q3 2012 115M +647K +0.57% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 115M +475K +0.42% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 115M +568K +0.5% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 114M +20M +21.1% Dec 31, 2011 10-K 2013-03-01
Q3 2011 114M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 114M Jun 30, 2011 10-Q 2011-08-05
Q1 2011 114M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 94.5M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.